Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
about
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-AnalysisMacrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast CancerNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityMyeloid Cells as Targets for Therapy in Solid TumorsNeutralizing tumor-promoting chronic inflammation: a magic bullet?Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exercise-induced immune modulation and exercise-induced myokinesTumor microenvironment and the pathologist: looking at what we just seeMechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissuesTumor ablation and nanotechnology.Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseLeukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyThe presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsThe tumor-immune microenvironment and response to radiation therapyEmodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune contextIntratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancerModern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibilityMRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticlesGene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancerTH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.Stromal cells in tumor microenvironment and breast cancerTumor intrinsic subtype is reflected in cancer-adjacent tissue.Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growthLeukocyte composition of human breast cancerCancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival RatesMonocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic modelDectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like PhenotypeInterferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular SubtypesFamily History of Cancer in Relation to Breast Cancer Subtypes in African American WomenTumor-associated macrophages: unwitting accomplices in breast cancer malignancy.Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.Harnessing the immune system for the treatment of breast cancer.
P2860
Q26748691-961EC414-D966-4271-B230-B079A223F31FQ26765377-E19C0860-A07C-42D3-B99E-CCEB2E35826DQ26773135-AD7E0265-22EE-4D63-983B-EE5FC4634A93Q26801832-4D1834EF-1168-40D7-9654-62916A6D8503Q26830931-3F15C241-55D8-4CEE-A9C7-F14DAD72C5D4Q26865918-F1A5B045-D6CA-48F1-8359-5A11D5B66A86Q26866052-DD757C37-FCA2-4D86-818D-B21A2FF228C6Q27003907-F44D5960-0C2A-45CD-837B-E5E32DD2D8A7Q28385067-3D0AB991-7786-46AD-AFC7-F379D37A4014Q28533543-71BEAE7B-8E64-4880-8A32-90D5C4B0331BQ29618033-54ABACAB-9479-4665-8464-C35881FA862AQ34348172-9DCFC4AC-A77D-4D83-AC13-A21DDBFFD0F5Q34444598-9D43460C-BEC4-43F2-ACAC-7F0A2762AEC9Q34475456-2E3900A0-FE5A-43F0-939C-8E2E54B0CB6CQ34718331-93E8B011-EAAD-4DE6-B6B2-ED7A0FCDDCD0Q35036920-72A75B78-1A24-4233-B076-A2FE5A56F619Q35151735-905A9FB2-A072-4E72-9EC8-E7BACC8DFB47Q35184055-F7327568-5255-42D1-8F3D-32B42AB8848FQ35196287-30939BAA-73D5-426E-955B-0EA0AF4E006EQ35314135-EC3C7CB6-385B-427F-9E01-B9DD05CFCD6AQ35463975-5C5CC096-4663-4653-B5AE-EDA7E2C9F2C1Q35572179-9CC5D7A8-3C8D-4C6D-9E64-1DD3AC06ED79Q35609967-09471009-6B11-482D-A9E4-D970C8564BEDQ35624103-6E83359F-6779-42C4-959A-7D7E3730A841Q35645125-058D5D52-A478-4C5F-9C9E-A9297B21A1DCQ35779386-8256B165-66DC-44CB-92DD-D44B14FE3F73Q35869025-526132C1-E944-4514-9F75-0A30F417FA90Q36039489-70C27E56-C042-45DC-8173-ABD605FC5E75Q36198192-25BDCBEC-22DB-4FF8-A13E-2BD4567D4911Q36245385-828E03BF-C2F6-49E7-94C7-DD6794BBBB08Q36260281-77CF2EB6-AB21-4297-8F2A-BCFF32FABFA5Q36317366-714CAEFC-A78F-49B3-9F8C-C750B4E87190Q36404526-1F7FEBB6-33A1-48B8-B3AC-484B38560429Q36619735-12D9EFD4-3029-4321-9932-4BE59C260C32Q36692838-0A7A66A9-1ECD-449E-8331-B68DC3D6150FQ36806793-544B74ED-ABE9-43C9-8308-7C77882FFED4Q37072929-6A95CFA2-6686-4E74-A9DB-88E00565C2F3Q37316047-48FBA341-7FFC-4284-9D96-B5EA6B9F00F8Q37456793-C6BBFE8A-F4A9-4CA5-AB4A-710B1093389BQ37476039-3B4ECA60-BC0B-459A-91AF-453E907EC602
P2860
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Proliferating macrophages asso ...... cer and poor clinical outcome.
@ast
Proliferating macrophages asso ...... cer and poor clinical outcome.
@en
type
label
Proliferating macrophages asso ...... cer and poor clinical outcome.
@ast
Proliferating macrophages asso ...... cer and poor clinical outcome.
@en
prefLabel
Proliferating macrophages asso ...... cer and poor clinical outcome.
@ast
Proliferating macrophages asso ...... cer and poor clinical outcome.
@en
P2093
P2860
P1476
Proliferating macrophages asso ...... cer and poor clinical outcome.
@en
P2093
Andrey I Khramtsov
Dan H Moore
David O Malaka
Dezheng Huo
Elisabeth R Garwood
Frederick Baehner
Laura J Esserman
P2860
P2888
P304
P356
10.1007/S10549-010-1154-Y
P407
P577
2010-09-15T00:00:00Z